Army tests new HIV vaccine strategy in early human trial
NCT ID NCT06205056
Summary
This is an early safety study testing two different schedules for an experimental HIV vaccine combination in healthy adults. The main goal is to see if the vaccines are safe and if they trigger an immune response. Researchers will compare a standard dosing schedule to a faster, escalating schedule to see which might better mimic how the body first encounters the real virus.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN IMMUNODEFICIENCY VIRUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Makerere University Walter Reed Project (MUWRP)
RECRUITINGKampala, Uganda
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.